BARDA Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

The latest BARDA Broad Agency Announcement (BAA) is amendment 14 posted on March 9, 2020.

Note: COVID-19 response related Areas of Interest includes:

AOI 7.7.1 Diagnostic assay for human coronavirus using existing FDA-cleared platforms
AOI 7.7.2 Point-of-care diagnostic assay for detection of SARS-CoV-2 virus
AOI 7.7.3 Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection)
AOI 8.3 COVID-19 Vaccine
AOI 9.2 COVID-19 Therapeutics
AOI 9.3 Immunomodulators or therapeutics targeting lung repair
AOI 9.5 Pre-exposure and post-exposure prophylaxis
AOI 10 Respiratory protective devices
AOI 11 Ventilators
AOI 17 Advanced Manufacturing Technologies